Phase 1 Safety Study of ACT-PFK-158, 2HCl in Patients With Advanced Solid Malignancies

PHASE1UnknownINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2015

Conditions

Cancer

Interventions

DRUG

PFK-158

IV dose escalation

Trial Locations (4)

RECRUITING

Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.

RECRUITING

James Graham Brown Cancer Center, Louisville

RECRUITING

MD Anderson Cancer Center, Houston

RECRUITING

UT Health Science Center at San Antonio, San Antonio